FIGURE 3.
(A) Coronal CT image and fusion of microPET and CT images (168 h after injection) enables adequate quantitative measurement of 89Zr-bevacizumab in the tumor; (B) Coronal planes of microPET images after injection of 89Zr-bevacizumab. Reproduced from Nagengast et al. 164 with permission.